Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
EVOGUARD
Phase 3 Double-blind Placebo-controlled Efficacy Trial of EVO100 Vaginal Gel for the Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
1 other identifier
interventional
1,892
1 country
98
Brief Summary
This study will evaluate whether EVO100 vaginal gel prevents the sexual transmission of CT and GC infection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Oct 2020
98 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2020
CompletedFirst Posted
Study publicly available on registry
September 17, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2022
CompletedResults Posted
Study results publicly available
January 30, 2024
CompletedJanuary 30, 2024
January 1, 2024
1.8 years
September 11, 2020
December 11, 2023
January 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of Study Successes in the EVO100 and Placebo Treatment Groups
Percentage of subjects who are defined study successes among the intervention groups with success defined as subjects completing the trial to Visit 5 without any CT or GC infection and no usage of prohibited antibiotics during the study.
16 weeks
Secondary Outcomes (1)
Evaluate Safety of EVO100: AEs
16 weeks
Study Arms (2)
EVO100 gel
EXPERIMENTALEVO100 vaginal gel, 5 g
Placebo gel
PLACEBO COMPARATORPlacebo vaginal gel, 5 g
Interventions
Eligibility Criteria
You may qualify if:
- Subjects must meet both of the following criteria:
- Urogenital CT and/or GC infection (documented in a retrievable medical record) within the 16 weeks prior to enrollment and one or more of the additional risk factors included below:
- to 24 years of age at the screening visit
- New sex partner within the past 12 weeks (84 days)
- More than one current sex partner
- Knowledge that current sex partner has multiple partners
- Partner with known sexually transmitted infection (STI)
- Inconsistent condom use among persons who are not in a mutually monogamous relationship
- After three unsuccessful documented attempts to obtain medical records, the subject has a self-reported history of infection less than 17 weeks prior to enrollment AND two or more of the following additional risk factors:
- to 24 years of age at the screening visit
- New sex partner within the past 12 weeks (84 days)
- More than one current sex partner
- Knowledge that current sex partner has multiple partners
- Partner with known STI
- Inconsistent condom use among persons who are not in a mutually monogamous relationship
- +8 more criteria
You may not qualify if:
- In the opinion of the Investigator, has a history of substance or alcohol abuse in the last 12 months or, has issues, conditions, or concerns that may compromise the safety of the subject, impact the subject's compliance with the protocol requirements, or confound the reliability of the data acquired
- Women who have undergone a total hysterectomy (had uterus and cervix removed). However, women with subtotal hysterectomy with an intact cervix may be enrolled
- Has a history or expectation of noncompliance with medications or intervention protocol
- Has engaged in sexual vaginal intercourse or douching, or used of any form of vaginal suppository or intravaginal device (with the exception of contraceptive vaginal ring or tampons) for 24 hours prior to enrollment (may be enrolled at a later date if all other criteria are met)
- Menstruating at enrollment (may be enrolled at a later date if all other criteria are met)
- Is currently being treated, or has been treated, for a period of 21 days prior to enrollment, with any prohibited antibiotics. The prohibited antibiotics include azithromycin, erythromycin, doxycycline, levofloxacin, ofloxacin, ceftriaxone, and cefixime.
- In the opinion of the Investigator, has signs/symptoms that indicate persistence of CT or GC infection diagnosed at screening, new interval infection, and/or a failure to comply with or complete the prescribed treatment regimen following a positive screening NAAT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Evofem Inc.lead
Study Sites (98)
Cahaba Medical Care
Birmingham, Alabama, 35218, United States
Mobile Obstetrics & Gynecology, P.C.
Mobile, Alabama, 36608, United States
Marchand OBGYN
Mesa, Arizona, 85209, United States
Onyx Clinical Research
Peoria, Arizona, 85381, United States
Precision Trials AZ, LLC
Phoenix, Arizona, 85032, United States
Applied Research Center of Arkansas
Little Rock, Arkansas, 72212, United States
Benchmark Research
Colton, California, 92324, United States
Join Clinical Trials
Huntington Park, California, 90255, United States
Matrix Clinical Research
Los Angeles, California, 90057, United States
Dream Team Clinical Research
Pomona, California, 91767, United States
Empire Clinical Research
Pomona, California, 91767, United States
University of California, Davis Medical Center
Sacramento, California, 95817, United States
UC San Diego Health, Womens Health Services La Jolla
San Diego, California, 92037, United States
Providere Research Inc
West Covina, California, 91790, United States
Planned Parenthood of Southern New England
New Haven, Connecticut, 06511, United States
Emerson Clinical Research Institute
Washington D.C., District of Columbia, 20011, United States
Ideal Clinical Research
Aventura, Florida, 33180, United States
Encore Medical Research, LLC
Hollywood, Florida, 33021, United States
Homestead Associates in Research
Miami, Florida, 33032, United States
South Florida Research Center, Inc.
Miami, Florida, 33135, United States
Pharmax Research of South Florida, Inc
Miami, Florida, 33175, United States
US Associates in Research, LLC
Miami, Florida, 33175, United States
Healthcare Clinical Data, Inc.
North Miami, Florida, 33161, United States
Clintheory Healthcare Miami
North Miami Beach, Florida, 33162, United States
Clinical Associates of Orlando, LLC
Orlando, Florida, 32819, United States
Bioresearch Institute Llc
Pembroke Pines, Florida, 33026, United States
Precision Clinical Research
Sunrise, Florida, 33351, United States
Comprehensive Clinical Research, LLC
West Palm Beach, Florida, 33409, United States
Encore Medical Research of Weston, LLC
Weston, Florida, 33331, United States
Visionaries Clinical Research, LLC
Atlanta, Georgia, 30318, United States
Agile Clinical Research Trials, LLC
Atlanta, Georgia, 30328, United States
Midtown OB GYN
Columbus, Georgia, 31901, United States
Columbus Regional Research Institute
Columbus, Georgia, 31904, United States
iResearch Atlanta, LLC
Decatur, Georgia, 30030, United States
Renew Health Clinical Research
Snellville, Georgia, 30078, United States
University Women's Health Specialists
Honolulu, Hawaii, 96826, United States
ASR,LLC
Nampa, Idaho, 83687, United States
Eagle Clinical Research
Chicago, Illinois, 60621, United States
Research Network America
Chicago, Illinois, 60643, United States
DelRicht Research
New Orleans, Louisiana, 70124, United States
DelRicht Research
Prairieville, Louisiana, 70769, United States
Continental Clinical Solutions
Towson, Maryland, 21204, United States
Boston Medical Center/Boston University Medical Campus
Boston, Massachusetts, 02118, United States
Onyx Clinical Research
Flint, Michigan, 48532, United States
Planned Parenthood North Central States - Minneapolis
Minneapolis, Minnesota, 55408, United States
Lintecum and Nickell, P.C.
Kansas City, Missouri, 64111, United States
Planned Parenthood of the St. Louis Region and Southwest Missouri - Central West End Health Center
St Louis, Missouri, 63108, United States
The Contraceptive Choice Center/Center for Outpatient Health - Women's Health Center
St Louis, Missouri, 63108, United States
Planned Parenthood of Northern, Central and Southern New Jersey
Elizabeth, New Jersey, 07201, United States
Planned Parenthood of Northern, Central and Southern New Jersey
Perth Amboy, New Jersey, 08861, United States
Analyzed Health Clinical Trials
New York, New York, 10016, United States
NYU Grossman School of Medicine/Bellevue Hospital Center
New York, New York, 10016, United States
Columbia University Irving Medical Center
New York, New York, 10032, United States
Urgent Care Clinical Trials @ AFC Urgent Care-Bronx
The Bronx, New York, 10465, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
Circuit Clinical/OB GYN Associates of WNY
West Seneca, New York, 14224, United States
Accellacare
Charlotte, North Carolina, 28209, United States
OnSite Clinical Solutions LLC
Charlotte, North Carolina, 28277, United States
Carolina Institute for Clinical Research
Fayetteville, North Carolina, 28303, United States
M3 Wake Research, Inc.
Raleigh, North Carolina, 27612, United States
Across the LifeSpan, PLLC
Yanceyville, North Carolina, 27379, United States
Seven Hills Clinical Research Group
Cincinnati, Ohio, 45242, United States
ClinOhio Research Services
Columbus, Ohio, 43213, United States
Complete Healthcare For Women
Columbus, Ohio, 43231, United States
DelRicht Research
Tulsa, Oklahoma, 74133, United States
Planned Parenthood Columbia Willamette
Portland, Oregon, 97236, United States
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Planned Parenthood Southeastern Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
UPMC Magee-Womens Hospital, Center for Family Planning Research
Pittsburgh, Pennsylvania, 15213, United States
Urgent Care Clinical Trials @ AFC Urgent Care-Easley
Easley, South Carolina, 29640, United States
Urgent Care Clinical Trials @ AFC Urgent Care-Powdersville
Powdersville, South Carolina, 29611, United States
Urgent Care Clinical Trials @ AFC Urgent Care-Clemson
Seneca, South Carolina, 29678, United States
WR-Medical Research Center of Memphis, LLC
Memphis, Tennessee, 38120, United States
Urgent Care Clinical Trials @ Complete Health Care Partners
Nashville, Tennessee, 37209, United States
Coastal Bend Clinical Research
Corpus Christi, Texas, 78413, United States
Urgent Care Clinical Trials @City Doc Urgent Care - McKinney
Dallas, Texas, 75204, United States
AIDS Arms, Inc. DBA Prism Health North Texas
Dallas, Texas, 75208, United States
Urgent Care Clinical Trials @City Doc Urgent Care-Inwood
Dallas, Texas, 75209, United States
Cedar Health Research
Dallas, Texas, 75251, United States
Synergy Groups Medical LLC
Houston, Texas, 77036, United States
Centex Studies, Inc.
Houston, Texas, 77058, United States
Synergy Groups Medical LLC
Houston, Texas, 77061, United States
Cypress Harmony Research, LLC
Houston, Texas, 77065, United States
Encore Imaging and Medical Research, LLC
Houston, Texas, 77065, United States
Texas Center for Drug Development, Inc.
Houston, Texas, 77081, United States
Spring Family Practice Associates PA
Houston, Texas, 77379, United States
MacArthur Medical Center
Irving, Texas, 75062, United States
Maximos Ob/Gyn
League City, Texas, 77573, United States
DCT-McAllen Primary Care Research dba Discovery Clinical Trials
McAllen, Texas, 78503, United States
Centex Studies, Inc.
McAllen, Texas, 78504, United States
Synergy Groups Medical LLC
Missouri City, Texas, 77459, United States
ARC Clinical Research at Kelly Lane
Pflugerville, Texas, 78660, United States
Storks Research, LLC
Sugar Land, Texas, 77479, United States
Virginia Women's Health Associates
Annandale, Virginia, 22003, United States
TPMG Clinical Research
Newport News, Virginia, 23606, United States
The Group for Women
Norfolk, Virginia, 23502, United States
MultiCare Health System - Rockwood Clinic Cheney
Cheney, Washington, 99004, United States
Planned Parenthood of the Great Northwest, Hawai'i, Alaska, Indiana, Kentucky - Tacoma Health Center
Tacoma, Washington, 98405, United States
Related Publications (1)
Thomas MA, Morlock R, Dart C, Howard B. Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study. J Sex Med. 2022 Jun;19(6):975-982. doi: 10.1016/j.jsxm.2022.03.221. Epub 2022 Apr 10.
PMID: 35418329DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Catherine Maher
- Organization
- Evofem
Study Officials
- STUDY DIRECTOR
Catherine Maher, PhD
Evofem Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2020
First Posted
September 17, 2020
Study Start
October 15, 2020
Primary Completion
July 28, 2022
Study Completion
July 28, 2022
Last Updated
January 30, 2024
Results First Posted
January 30, 2024
Record last verified: 2024-01